GlassScriptPhysician profile
Kent Elliot Berkey
NPI 1396943742
$11,106.91
in general payments reported to CMS, 2019-2025
56 companies · $1,240 in 2025
The $1,240 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,050 · 2020: $1,836 · 2021: $1,660 · 2022: $1,494 · 2023: $1,541 · 2024: $1,286 · 2025: $1,240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,969 · Education: $97.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,969.32 |
| Education | $97.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,088.67 | 2021-2025 | Botox, Ubrelvy |
| Novartis Pharmaceuticals Corporation | $1,343.64 | 2019-2025 | |
| Allergan, INC. | $851.00 | 2019-2022 | |
| Emd Serono, INC. | $508.10 | 2019-2025 | Mavenclad |
| Sk Life Science, INC. | $443.14 | 2020-2025 | |
| Acorda Therapeutics, INC | $442.65 | 2019-2024 | Inbrija |
| Teva Pharmaceuticals USA, INC. | $427.46 | 2019-2024 | Austedo Xr |
| Mdd US Operations, LLC | $353.54 | 2019-2024 | Gocovri, Apokyn |
| Ucb, INC. | $345.54 | 2019-2024 | Zilbrysq |
| Pfizer INC. | $323.16 | 2019-2025 | |
| Biogen, INC. | $320.07 | 2019-2025 | Tysabri, Vumerity |
| Acadia Pharmaceuticals INC | $272.61 | 2019-2025 | Nuplazid |
| Alexion Pharmaceuticals, INC. | $236.36 | 2019-2025 | Ultomiris |
| Amneal Pharmaceuticals LLC | $198.47 | 2019-2025 | Crexont |
| Genzyme Corporation | $173.84 | 2019-2023 |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Berkey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.